참고문헌
- Nguyen Y, Stirnemann J, Belmatoug N. Gaucher disease: A review. Rev Med Interne 2019;40:313-22. https://doi.org/10.1016/j.revmed.2018.11.012
- Eghbali A, Hassan S, Seehra G, FitzGibbon E, Sidransky E. Ophthalmological findings in Gaucher disease. Mol Genet Metab 2019;127:23-7. https://doi.org/10.1016/j.ymgme.2019.02.002
- Sheth J, Bhavsar R, Mistri M, Pancholi D, Bavdekar A, Dalal A, et al. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation. BMC Med Genet 2019;20:31. https://doi.org/10.1186/s12881-019-0759-1
- Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, et al. An review of gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci 2017;17:18(2).
- Weiss K, Gonzalez A, Lopez G, Pedoeim L, Groden C, Sidransky E. The clinical management of Type 2 Gaucher disease. Mol Genet Metab 2015;114:110-22. https://doi.org/10.1016/j.ymgme.2014.11.008
- Emanuel AJ, Holman N, Presnell SE, Welsh CT, Pai S, Sun S. Small bowel mucosal involvement and mesenteric mass formation in a young female with Type 3 Gaucher disease. A case report. J Gastrointestin Liver Dis 2018;27:459-63. https://doi.org/10.15403/jgld.2014.1121.274.bow
- Sechi A, Deroma L, Dardis A, Ciana G, Bertin N, Concolino D, et al. Long term effects of enzyme replacement therapy in an Italian cohort of type 3 Gaucher patients. Mol Genet Metab 2014;113:213-8. https://doi.org/10.1016/j.ymgme.2014.07.022
- Kim EA, Lim YT, Hah JO, Sohn YB, Kim YK, Choi JH, et al. Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia. Int J Hematol 2019;109:361-5. https://doi.org/10.1007/s12185-018-2559-3
- Bremova-Ertl T, Schiffmann R, Patterson MC, Belmatoug N, Billette de Villemeur T, Bardins S, et al. Oculomotor and vestibular findings in Gaucher disease Type 3 and their correlation with neurological findings. Front Neurol 2018;8:711. https://doi.org/10.3389/fneur.2017.00711
- Charkhand B, Scantlebury MH, Narita A, Zimran A, Al-Hertani W. Effect of Ambroxol chaperone therapy on Glucosylsphingosine (Lyso-Gb1) levels in two Canadian patients with type 3 Gaucher disease. Mol Genet Metab Rep 2019;20:100476. https://doi.org/10.1016/j.ymgmr.2019.100476
- Lee JY, Lee BH, Kim GH, Jung CW, Lee J, Choi JH, et al. Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups. Korean J Pediatr 2012;55:48-53. https://doi.org/10.3345/kjp.2012.55.2.48